Academic Journal
Q1Molecular Therapy
About Molecular Therapy
Molecular Therapy is a scholarly journal published by Cell Press. SCImago 2025 places it in Q1 with an SJR of 3.814 and an H-index of 233.
Its listed coverage is 2000-2026 and its research categories include Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1). The 2025 dataset reports 519 documents and 8788 citations across the latest three-year reporting window.
Journal Metrics
Metrics can change by reporting year. Verify time-sensitive values with the publisher or indexing service.
Aims & Scope
The journal publishes research related to Virus-based gene therapy research, RNA Interference and Gene Delivery, CRISPR and Genetic Engineering, Viral Infectious Diseases and Gene Expression in Insects, CAR-T cell therapy research, Cancer Research and Treatments.
Recent Research Articles
Latest publications matched automatically by ISSN.
Breaking the delivery barrier: Advancing gene therapy for adult-onset hearing loss
Jerusha Naidoo
2026-09 · DOI: 10.1016/j.ymthe.2026.08.044Christopher D. Porada, PhD (1969–2026): In memoriam
Roland W. Herzog, Graça Almeida-Porada
2026-09 · DOI: 10.1016/j.ymthe.2026.08.023Increasing intrinsic protein disorder improves CD8+ immunogenicity for a SARS CoV2 vaccine candidate antigen
Li Wan, Bingxian Xie, Masahiro Shuda, Maura E. O'Malley et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.06.027Discovery of TCR-like antibodies to the KRAS G12D neoantigen via in silico-in vitro workflow
SangPhil Ahn, Tae-Sung Oh, Seonghyuk Suh, Joon-Young Jeon et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.05.032Development of novel GPC2-directed radiotheranostics and CAR T cell therapy for neuroblastoma
Ira Phadke, Divya Nambiar, George Diehl, Joon-Yong Chung et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.05.030Advancing variant agnostic liver-directed gene editing using homology-independent targeted integration
Michael A. Martinez, Cary O. Harding
2026-09 · DOI: 10.1016/j.ymthe.2026.08.015Disruption of Circulating Extracellular Vesicles as a Novel Therapeutic Strategy against Cancer Metastasis
Nao Nishida-Aoki, Naoomi Tominaga, Fumitaka Takeshita, Hikaru Sonoda et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.08.001Targeting emerging respiratory pathogens with clamp peptides: Broad-spectrum inhibition of viral entry in 3D human lung models
Mercedes Lozano-Garcia, Josep-Ramon Codina, Marcello Mascini, Emre Dikici et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.06.020Optimization of AsCas12f1-Mediated Long-Term Gene Repression
Yangyang Sun, Linyun Li, Xiangnan Wang, Linxiao Han et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.09.001Inhaled nanosilica orchestrates a pulmonary macrophage-NK cell axis for memory-like NK programming toward synergistic cancer immunotherapy
Feng Yuan, Qi Li, Yingnan Liu, Fangfang Liu et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.08.046Treatment of spinal injury muscle spasticity by spinal subpial AAV9-GAD65/VGAT delivery: An efficacy and safety study in rat, pig, and NHP
Duong Nguyen, Tetsuya Yoshizumi, Masanori Sawamura, Kirill Agashkov et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.06.008miR-146a mimic therapy protects against platelet-mediated thrombosis
Sonia Águila, Juan C. García-Cañaveras, Laura Zapata-Martínez, Ana B. Arroyo et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.07.019Long-term functional synaptic integration of genome-edited retinal organoids in a primate model of macular degeneration
Atsuta Ozaki, Akihiro Kawai, Ryutaro Akiba, Satoko Okayama et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.06.037Cell-penetrating asymmetric siRNA targeting MyD88 suppresses inflammasome-driven ocular degeneration and angiogenesis
Juhong Kim, Saehong Min, Munjeong Yum, Sujin Park et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.06.036Transgene sequence codon optimization and composition determines replication competence of self-amplifying RNA
Nuthan Vikas Bathula, Shekinah K.V. Soriano, Cynthia Huang, Eric Jan et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.07.004Are the current preclinical models adequate to evaluate CAR-T cell therapy in pediatric high-grade gliomas?
Ana Muñoz Grau, Fatima Hameedat, Bibi Sumayyah Hussein Sokeechand, Chitra Venugopal et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.06.043Programmable engineered bacteria manipulate metabolism and remodel the TME in situ for enhancing adoptive cell therapy
Jin Chen, Tianliang Liu, Xiumin Liu, Hongyue Zhang et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.06.042A compact GAD67 promoter enables inhibitory neuron-targeted AAV gene therapy for seizure suppression
Yuuki Fukai, Ayumu Konno, Nobutake Hosoi, Karin Miyakawa et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.06.007DDX3X overexpression in mice can cause rapid tissue-specific toxicity and mortality
Andrea Boitnott, Yuhui Hu, Mary Wight-Carter, Christian Lopez Escobar et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.07.032Targeting white matter astrocytes with a Gfap-disruptive Cas9 nuclease benefits a murine model of Alexander disease
Anne E.J. Hillen, Irene Capuano, Barbara Gega, Rossana Norata et al.
2026-09 · DOI: 10.1016/j.ymthe.2026.09.019Reviews
Community Reviews
Version History
September 8, 2026 at 12:07 am
September 8, 2026